actinium has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giesel, F; Haberkorn, U; Hatazawa, J; Kaneda-Nakashima, K; Kratochwil, C; Lindner, T; Liu, Y; Nagata, K; Ooe, K; Shimosegawa, E; Shinohara, A; Shirakami, Y; Toyoshima, A; Watabe, T | 1 |
| Chea, J; Colcher, D; Li, L; Liu, A; Miller, AD; Minnix, M; Poku, E; Rockne, RC; Shively, JE; Wong, JYC; Yazaki, PJ | 1 |
2 other study(ies) available for actinium and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
Topics: Actinium; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Endopeptidases; Gelatinases; Humans; Isotope Labeling; Male; Membrane Proteins; Mice; Mice, Nude; Molecular Targeted Therapy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Serine Endopeptidases; Tissue Distribution | 2020 |
TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Molecular Targeted Therapy; Ovarian Neoplasms; Radioimmunotherapy; Tissue Distribution | 2021 |